RecruitingChronic Low-back PainVertebrogenic Pain Syndrome
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Eligible age
18+ yrs
Accepts
All genders
Locations
16 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Sponsor: Boston Scientific Corporation
You may qualify if…
- ✓ Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
- ✓ Signed a valid, IRB/EC-approved informed consent form.
You may not qualify if…
- ✕ Meets any contraindications per locally applicable Instructions for Use (IFU).
Where it's recruiting
Arizona
Flagstaff · Phoenix
California
Larkspur
Connecticut
Westport
District of Columbia
Washington D.C.
Florida
Orlando
Idaho
Post Falls
Illinois
Barrington
Kentucky
Lexington
Louisiana
New Orleans
Minnesota
Maple Grove
New York
Port Jefferson Station · Rochester
North Carolina
Bermuda Run
Source: ClinicalTrials.gov · NCT06827262 · last updated 2026-06-24